Clinical trials
Phase 2 Leukemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Novartis Pharmaceuticals | 4 |
| Pfizer | 2 |
| AbbVie | 1 |
| Amgen Research (Munich) GmbH | 1 |
| Bristol-Myers Squibb | 1 |
| Cogent Biosciences, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Radboud University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 22 |
| Leukemia, Myeloid, Acute | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Recurrence | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Hematologic Diseases | 2 |
| Leukemia, Erythroblastic, Acute | 2 |
| Leukemia, Mast-Cell | 2 |
| Leukemia, Megakaryoblastic, Acute | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.